Published in Plant J on March 21, 2011
Plant peroxisomes: biogenesis and function. Plant Cell (2012) 1.97
The roles of reactive oxygen metabolism in drought: not so cut and dried. Plant Physiol (2014) 1.23
Ribosomal readthrough at a short UGA stop codon context triggers dual localization of metabolic enzymes in Fungi and animals. PLoS Genet (2014) 0.98
Putative role of the malate valve enzyme NADP-malate dehydrogenase in H2O2 signalling in Arabidopsis. Philos Trans R Soc Lond B Biol Sci (2014) 0.89
Dual targeting of peroxisomal proteins. Front Physiol (2013) 0.89
Defining the plant peroxisomal proteome: from Arabidopsis to rice. Front Plant Sci (2011) 0.82
Defects in Peroxisomal 6-Phosphogluconate Dehydrogenase Isoform PGD2 Prevent Gametophytic Interaction in Arabidopsis thaliana. Plant Physiol (2016) 0.81
Chloroplast-localized 6-phosphogluconate dehydrogenase is critical for maize endosperm starch accumulation. J Exp Bot (2013) 0.81
Metabolic control of redox and redox control of metabolism in plants. Antioxid Redox Signal (2014) 0.80
Suppression of NDA-type alternative mitochondrial NAD(P)H dehydrogenases in arabidopsis thaliana modifies growth and metabolism, but not high light stimulation of mitochondrial electron transport. Plant Cell Physiol (2014) 0.79
The rare sugar D-allose acts as a triggering molecule of rice defence via ROS generation. J Exp Bot (2013) 0.79
Redox regulated peroxisome homeostasis. Redox Biol (2014) 0.77
Post-translational regulation of plant immunity. Curr Opin Plant Biol (2017) 0.77
Plant peroxisomes: recent discoveries in functional complexity, organelle homeostasis, and morphological dynamics. Curr Opin Plant Biol (2016) 0.76
Towards understanding peroxisomal phosphoregulation in Arabidopsis thaliana. Planta (2015) 0.76
Analysis of homo- and hetero-dimerization among the three 6-phosphogluconate dehydrogenase isoforms of Arabidopsis. Plant Signal Behav (2016) 0.75
Nitrogen Assimilation, Abiotic Stress and Glucose 6-Phosphate Dehydrogenase: The Full Circle of Reductants. Plants (Basel) (2016) 0.75
Acetolactate synthase regulatory subunits play divergent and overlapping roles in branched-chain amino acid synthesis and Arabidopsis development. BMC Plant Biol (2017) 0.75
Abeta42-driven cerebral amyloidosis in transgenic mice reveals early and robust pathology. EMBO Rep (2006) 4.06
Nanoparticles that communicate in vivo to amplify tumour targeting. Nat Mater (2011) 3.83
Infarction of tumor vessels by NGR-peptide-directed targeting of tissue factor: experimental results and first-in-man experience. Blood (2009) 2.54
The oxidative pentose phosphate pathway: structure and organisation. Curr Opin Plant Biol (2003) 2.34
The diabetes drug liraglutide prevents degenerative processes in a mouse model of Alzheimer's disease. J Neurosci (2011) 1.97
Salt tolerance of Arabidopsis thaliana requires maturation of N-glycosylated proteins in the Golgi apparatus. Proc Natl Acad Sci U S A (2008) 1.63
Drugs developed to treat diabetes, liraglutide and lixisenatide, cross the blood brain barrier and enhance neurogenesis. BMC Neurosci (2012) 1.60
Pattern recognition receptors require N-glycosylation to mediate plant immunity. J Biol Chem (2009) 1.58
Common pathological processes in Alzheimer disease and type 2 diabetes: a review. Brain Res Rev (2007) 1.44
Intranasal insulin as a treatment for Alzheimer's disease: a review of basic research and clinical evidence. CNS Drugs (2013) 1.30
Receptors for the incretin glucagon-like peptide-1 are expressed on neurons in the central nervous system. Neuroreport (2009) 1.22
Isoenzyme replacement of glucose-6-phosphate dehydrogenase in the cytosol improves stress tolerance in plants. Proc Natl Acad Sci U S A (2009) 1.11
Glucagon-like peptide-1 analogues enhance synaptic plasticity in the brain: a link between diabetes and Alzheimer's disease. Eur J Pharmacol (2009) 1.10
Impairment of synaptic plasticity and memory formation in GLP-1 receptor KO mice: Interaction between type 2 diabetes and Alzheimer's disease. Behav Brain Res (2009) 1.08
Investigation of the human brain metabolome to identify potential markers for early diagnosis and therapeutic targets of Alzheimer's disease. Anal Chem (2013) 1.08
Differential regulation of glucose-6-phosphate dehydrogenase isoenzyme activities in potato. Plant Physiol (2003) 1.07
GSK3: a key target for the development of novel treatments for type 2 diabetes mellitus and Alzheimer disease. Rev Neurosci (2011) 1.02
Val(8)GLP-1 rescues synaptic plasticity and reduces dense core plaques in APP/PS1 mice. Neurobiol Aging (2010) 1.02
Comparative analyses of Arabidopsis complex glycan1 mutants and genetic interaction with staurosporin and temperature sensitive3a. Plant Physiol (2008) 1.00
Inhibition of tumor growth by RGD peptide-directed delivery of truncated tissue factor to the tumor vasculature. Clin Cancer Res (2005) 1.00
Synaptic plasticity in the hippocampus of a APP/PS1 mouse model of Alzheimer's disease is impaired in old but not young mice. PLoS One (2010) 1.00
Liraglutide can reverse memory impairment, synaptic loss and reduce plaque load in aged APP/PS1 mice, a model of Alzheimer's disease. Neuropharmacology (2013) 0.99
Fragmentation of intra-peptide and inter-peptide disulfide bonds of proteolytic peptides by nanoESI collision-induced dissociation. Anal Bioanal Chem (2008) 0.99
Regulatory subunit B'gamma of protein phosphatase 2A prevents unnecessary defense reactions under low light in Arabidopsis. Plant Physiol (2011) 0.98
GLP-1 agonists facilitate hippocampal LTP and reverse the impairment of LTP induced by beta-amyloid. Eur J Pharmacol (2008) 0.97
Decreased content of leaf ferredoxin changes electron distribution and limits photosynthesis in transgenic potato plants. Plant Physiol (2003) 0.97
The type 2 diabetes drug liraglutide reduces chronic inflammation induced by irradiation in the mouse brain. Eur J Pharmacol (2012) 0.91
A novel retro-inverso peptide inhibitor reduces amyloid deposition, oxidation and inflammation and stimulates neurogenesis in the APPswe/PS1ΔE9 mouse model of Alzheimer's disease. PLoS One (2013) 0.90
Neuroprotective and anti-apoptotic effects of liraglutide on SH-SY5Y cells exposed to methylglyoxal stress. J Neurochem (2013) 0.88
Prolonged GIP receptor activation improves cognitive function, hippocampal synaptic plasticity and glucose homeostasis in high-fat fed mice. Eur J Pharmacol (2010) 0.88
Paracrine interactions of vascular endothelial growth factor and platelet-derived growth factor in endothelial and lung cancer cells. Int J Oncol (2007) 0.88
Glucose-dependent insulinotropic polypeptide receptor knockout mice are impaired in learning, synaptic plasticity, and neurogenesis. J Neurophysiol (2011) 0.88
Liraglutide protects against amyloid-β protein-induced impairment of spatial learning and memory in rats. Neurobiol Aging (2012) 0.88
Osteopontin is a prognostic factor for survival of acute myeloid leukemia patients. Blood (2012) 0.86
Reduced immunogenicity of Arabidopsis hgl1 mutant N-glycans caused by altered accessibility of xylose and core fucose epitopes. J Biol Chem (2011) 0.86
Protease-resistant glucose-dependent insulinotropic polypeptide agonists facilitate hippocampal LTP and reverse the impairment of LTP induced by beta-amyloid. J Neurophysiol (2008) 0.86
Chronic treatment with the GLP1 analogue liraglutide increases cell proliferation and differentiation into neurons in an AD mouse model. PLoS One (2013) 0.85
Reduction of cross-reactive carbohydrate determinants in plant foodstuff: elucidation of clinical relevance and implications for allergy diagnosis. PLoS One (2011) 0.83
Generation of fusion proteins for selective occlusion of tumor vessels. Curr Drug Discov Technol (2008) 0.83
Effects of acute and chronic administration of GIP analogues on cognition, synaptic plasticity and neurogenesis in mice. Eur J Pharmacol (2011) 0.83
Dual-targeting of Arabidopsis 6-phosphogluconolactonase 3 (PGL3) to chloroplasts and peroxisomes involves interaction with Trx m2 in the cytosol. Mol Plant (2013) 0.83
Compounds in clinical Phase III and beyond. Recent Results Cancer Res (2010) 0.82
Analysis of a novel highly metastatic melanoma cell line identifies osteopontin as a new lymphangiogenic factor. Int J Oncol (2012) 0.81
Val⁸-GLP-1 remodels synaptic activity and intracellular calcium homeostasis impaired by amyloid β peptide in rats. J Neurosci Res (2013) 0.80
Actions of incretin metabolites on locomotor activity, cognitive function and in vivo hippocampal synaptic plasticity in high fat fed mice. Peptides (2012) 0.80
Extracellular matrix composition and interstitial pH modulate NHE1-mediated melanoma cell motility. Int J Oncol (2013) 0.79
Impairments of hippocampal synaptic plasticity induced by aggregated beta-amyloid (25-35) are dependent on stimulation-protocol and genetic background. Exp Brain Res (2006) 0.79
New animal models of Alzheimer's disease that display insulin desensitization in the brain. Rev Neurosci (2013) 0.79
Non-invasive monitoring of tumor-vessel infarction by retargeted truncated tissue factor tTF-NGR using multi-modal imaging. Angiogenesis (2013) 0.78
Restoration of cerebral and systemic microvascular architecture in APP/PS1 transgenic mice following treatment with Liraglutide™. Microcirculation (2015) 0.78
D-Ala2GIP facilitated synaptic plasticity and reduces plaque load in aged wild type mice and in an Alzheimer's disease mouse model. J Alzheimers Dis (2013) 0.77
Neuroprotective effects of glucose-dependent insulinotropic polypeptide in Alzheimer's disease. Rev Neurosci (2016) 0.77
A novel dual-glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide receptor agonist is neuroprotective in transient focal cerebral ischemia in the rat. Neuroreport (2016) 0.76
Effects of the glucagon-like polypeptide-1 analogue (Val8)GLP-1 on learning, progenitor cell proliferation and neurogenesis in the C57B/16 mouse brain. Brain Res (2012) 0.76
Inactivation of the rat dorsal striatum impairs performance in spatial tasks and alters hippocampal theta in the freely moving rat. Behav Brain Res (2005) 0.76
Neuroprotective effects of geniposide on Alzheimer's disease pathology. Rev Neurosci (2015) 0.76
Vascular infarction by subcutaneous application of tissue factor targeted to tumor vessels with NGR-peptides: activity and toxicity profile. Int J Oncol (2010) 0.76
A novel dual GLP-1 and GIP incretin receptor agonist is neuroprotective in a mouse model of Parkinson's disease by reducing chronic inflammation in the brain. Neuroreport (2016) 0.75
Therapeutic potential of flavonoids in spinal cord injury. Rev Neurosci (2017) 0.75
Correction: Potential therapeutic impact of CD13 expression in non-small cell lung cancer. PLoS One (2017) 0.75
Incretin-based therapy for type 2 diabetes mellitus is promising for treating neurodegenerative diseases. Rev Neurosci (2016) 0.75